MX2022015060A - Composición que comprende oligosacárido de glucosa y proceso para elaborar la misma y usarla. - Google Patents
Composición que comprende oligosacárido de glucosa y proceso para elaborar la misma y usarla.Info
- Publication number
- MX2022015060A MX2022015060A MX2022015060A MX2022015060A MX2022015060A MX 2022015060 A MX2022015060 A MX 2022015060A MX 2022015060 A MX2022015060 A MX 2022015060A MX 2022015060 A MX2022015060 A MX 2022015060A MX 2022015060 A MX2022015060 A MX 2022015060A
- Authority
- MX
- Mexico
- Prior art keywords
- composition
- glucose oligosaccharide
- making
- same
- present
- Prior art date
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract 5
- 239000008103 glucose Substances 0.000 title abstract 5
- -1 glucose oligosaccharide Chemical class 0.000 title abstract 5
- 229920001542 oligosaccharide Polymers 0.000 title abstract 5
- 210000000987 immune system Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Animal Husbandry (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Birds (AREA)
- Physiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Saccharide Compounds (AREA)
Abstract
La presente invención se relaciona con una composición que comprende oligosacárido de glucosa y con un proceso para elaborarla. La presente invención se relaciona además con una composición que comprende oligosacárido de glucosa para usarse en el tratamiento de un animal. La presente invención se relaciona además con el uso de una composición que comprende oligosacárido de glucosa para mejorar el rendimiento del crecimiento de un animal. La presente invención se relaciona además con el uso de una composición que comprende oligosacárido de glucosa para mejorar la modulación del sistema inmunitario de un animal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20177583 | 2020-05-29 | ||
PCT/US2021/034717 WO2021243125A1 (en) | 2020-05-29 | 2021-05-28 | Composition comprising glucose oligosaccharide and process for making the same and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022015060A true MX2022015060A (es) | 2023-03-06 |
Family
ID=70968846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022015060A MX2022015060A (es) | 2020-05-29 | 2021-05-28 | Composición que comprende oligosacárido de glucosa y proceso para elaborar la misma y usarla. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20230190778A1 (es) |
EP (1) | EP4156976A1 (es) |
CN (1) | CN115720490A (es) |
BR (1) | BR112022024217A2 (es) |
CA (1) | CA3180391A1 (es) |
MX (1) | MX2022015060A (es) |
WO (1) | WO2021243125A1 (es) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2626583B1 (fr) | 1988-01-29 | 1991-03-15 | Bioeurope | Procede de preparation enzymatique d'oligodextranes utiles dans la fabrication de substituts du sucre, et nouveaux oligodextranes |
CN104987432A (zh) * | 2008-08-20 | 2015-10-21 | 卡吉尔公司 | 新型聚葡萄糖材料 |
US8435590B2 (en) * | 2008-11-24 | 2013-05-07 | Stokely-Van Camp, Inc. | Use of novel carbohydrates and carbohydrate blends to provide a sports beverage with increased absorption |
JP4966429B1 (ja) * | 2011-01-07 | 2012-07-04 | 日本食品化工株式会社 | 糖縮合物並びにその製造方法および用途 |
EP2983514A4 (en) * | 2013-03-15 | 2017-03-15 | Cargill, Incorporated | Carbohydrate compositions |
CN103833868A (zh) * | 2013-12-26 | 2014-06-04 | 江南大学 | 一种巨寡糖的快速制备方法 |
CN103766695B (zh) * | 2013-12-26 | 2015-05-20 | 江南大学 | 一种分子量可控聚葡萄糖及其快速制备方法 |
SI3071235T1 (en) * | 2015-01-26 | 2018-04-30 | Kaleido Biosciences, Inc. | THERAPEUTIC GLITTERS AND THE RELATED METHOD |
WO2017083520A1 (en) * | 2015-11-13 | 2017-05-18 | Cadena Bio, Inc. | Animal therapeutic and feed compositions and methods of use |
CN110753550A (zh) * | 2017-06-14 | 2020-02-04 | 嘉吉公司 | 包含甘露糖寡糖的组合物及其制备方法和用途 |
CN113645850A (zh) * | 2018-11-08 | 2021-11-12 | 帝斯曼知识产权资产管理有限公司 | 调节胃肠代谢物的方法 |
-
2021
- 2021-05-28 MX MX2022015060A patent/MX2022015060A/es unknown
- 2021-05-28 US US17/999,613 patent/US20230190778A1/en active Pending
- 2021-05-28 BR BR112022024217A patent/BR112022024217A2/pt unknown
- 2021-05-28 EP EP21732789.9A patent/EP4156976A1/en active Pending
- 2021-05-28 WO PCT/US2021/034717 patent/WO2021243125A1/en active Application Filing
- 2021-05-28 CA CA3180391A patent/CA3180391A1/en active Pending
- 2021-05-28 CN CN202180044605.9A patent/CN115720490A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2021243125A1 (en) | 2021-12-02 |
EP4156976A1 (en) | 2023-04-05 |
BR112022024217A2 (pt) | 2023-01-24 |
US20230190778A1 (en) | 2023-06-22 |
CA3180391A1 (en) | 2021-12-02 |
CN115720490A (zh) | 2023-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112021020616A2 (pt) | Novos métodos de tratamento de sementes e composições para o aprimoramento dos traços e rendimento de plantas | |
WO2021231237A3 (en) | Antibodies for sars-cov-2 and uses thereof | |
EA201490512A1 (ru) | Композиции, содержащие культивируемую в анаэробных условиях микробиоту кишечника человека | |
MX2016003268A (es) | Cepa aislada de clonostachys rosea para usarse como un agente de control biologico. | |
MX2022010542A (es) | Composiciones y metodos para reducir la expresion de citocinas. | |
EP4344740A3 (en) | Treatment of pain with polysulfated polysaccharides | |
WO2023288007A9 (en) | Expansion of memory natural killer cells | |
PH12020500049A1 (en) | Compositions of and methods for producing fermented agricultural biomass | |
WO2022122830A3 (en) | Modification of saponins | |
MX2022015060A (es) | Composición que comprende oligosacárido de glucosa y proceso para elaborar la misma y usarla. | |
WO2021216687A9 (en) | Peptides for the treatment of covid-19 | |
MX2022002541A (es) | Agente bioestimulante para tratar plantas y/o semillas de plantas. | |
MX2024005649A (es) | Proteinas quimericas basadas en sirp1a y cd40l. | |
MX2021006808A (es) | Novedosa psicosa-6-fosfato fosfatasa, composicion para la produccion de psicosa que comprende la misma y procedimiento para la produccion de psicosa mediante el uso de la misma. | |
MX2024007178A (es) | Metodos de tratamiento de semillas y plantas para reducir enfermedades transmitidas por alimentos. | |
MX2019012543A (es) | Metodo para mejorar la seguridad de los cultivos. | |
MX2024001304A (es) | Composiciones y metodos para anticuerpos anti-pacap. | |
MX2023014969A (es) | Trampas de ligando del factor de crecimiento transformante beta para el tratamiento de enfermedades. | |
WO2022118016A3 (en) | Enzyme inhibitors | |
PH12021550962A1 (en) | Composition comprising sulphated galactose, and implementations thereof | |
MX2022012109A (es) | Uso de la fitasa para obtener alimentos mejorados. | |
MX2021015155A (es) | Polisacaridos de ramnosa. | |
MX2023005014A (es) | Metodos de tratamiento de enfermedades inflamatorias cronicas. | |
EP4257128A3 (en) | Methods and compounds for the treatment of genetic disease | |
WO2019078646A3 (ko) | 콩 배양조직 추출물을 포함하는 탈모방지 또는 육모촉진용 조성물 및 이의 제조방법 |